You are here: Fairness.com > Resources > European Commission Is Expected to ...
European Commission Is Expected to Rule That AstraZeneca Abused Patent
- Date: June 15, 2005
- QUOTE: "After an investigation that took several years, the commission's antitrust division decided that AstraZeneca prevented generic drug makers from marketing a cheaper version of Losec, even though its patent protection had expired, the person said on condition of anonymity."
-
- Read it: New York Times
- Tell a friend
- Add a Comment*
Article MetaInformation:
- Key People:
-
- Key Organizations:
- Subject & Geographic Categories:
Comments:
- none
- *User comments are posted without Fairness.com LLC's prior review or approval, and Fairness.com LLC takes no responsibility for them; please see our Conditions of Service Agreement.
Services
Subject Categories
- Arts & Humanities
- Businesses & Organizations
- Computers & Information Technology
- Education
- Family & Friends & Interpersonal
- Government & Politics / History
- Health & Medicine
- Law & Justice
- Media & Journalism
- Personal Finance & Career
- Philosophy & Religion
- Recreation & Entertainment
- Science & Technology
- Social Sciences & Groups
Geographic Categories
- Africa
- Arctic / Antarctic / Greenland
- Asia
- Central America / Caribbean
- Eurasia / Central Asia
- Europe
- Middle East
- North America
- Oceania / AustralAsia
- South America
- Worldwide
About Fairness.com
- FAQ
- About Fairness.com
- Contact Us
- Conditions of Service
- Privacy Policy
- Fair Use Notice
- Advisory Board
- Acknowledgements
Volunteer Opportunities
Log In
Not a current user? Sign up!